The ZetaView® x30 adds multi-laser fluorescence and an extended optical path to nanoparticle tracking — so you can distinguish CD9, CD63, and CD81 subpopulations on individual vesicles, even in complex or turbid samples, with data integrity built for regulated workflows.
Where the Evolution measures size, concentration, zeta, and single-channel fluorescence, the x30 extends the platform with multiple laser lines and a longer optical path. That combination is what lets it pull apart overlapping vesicle subtypes — the CD9-only, CD63-only, and co-labelled populations that a single channel blends together.
It is built for labs bridging discovery to manufacturing: the same instrument that resolves a research question also generates the audited, traceable records a release assay needs.
Each particle in the field carries its own combination of surface markers. Switch laser channels on and off to reveal which subpopulations light up — and which vesicles are co-labelled across two or three markers at once.
Toggle channels. A particle gains a coloured ring for every active marker it carries; two or three rings means a genuinely co-labelled vesicle — the phenotype bulk assays average away.
Separate CD9 / CD63 / CD81 populations, VLPs, and engineered nanocarriers on individual particles.
Higher resolution in complex or turbid samples where single-path systems struggle.
Electronic records and signatures with the data-integrity tools regulated submissions expect.
Multiparameter tracking in one workflow — no moving the sample between instruments.
Reproducible across sites, from a single research group to industrial bioproduction.
Data-integrity features that support regulatory filings across major agencies.
Differentiate heterogeneous EV populations by surface phenotype.
Characterise lipid nanoparticles for drug and gene delivery.
Release testing for viral vectors and nanoparticle products.
Fluorescently labelled exosome and virus detection assays.
For Research Use Only. Not for use in diagnostic procedures.